Treatment with dasatinib or nilotinib in chronic myeloid leukemia patients who failed to respond to two previously administered tyrosine kinase inhibitors – a single center experience

Autor: Ribeiro, Beatriz Felicio, Miranda, Eliana C M, de Albuquerque, Dulcinéia Martins, Delamain, Márcia T, Oliveira-Duarte, Gislaine, Almeida, Maria Helena, Vergílio, Bruna, da Silveira, Rosana Antunes, Oliveira-Duarte, Vagner, Lorand-Metze, Irene, De Souza, Carmino A, Pagnano, Katia B B *
Zdroj: In Clinics August 2015 70(8):550-555
Databáze: ScienceDirect